MOORE CRAIG W 4
4 · NxStage Medical, Inc. · Filed Feb 25, 2019
Insider Transaction Report
Form 4
MOORE CRAIG W
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−23,394→ 0 totalExercise: $13.16From: 2014-05-22Exp: 2024-05-21→ Common Stock (23,394 underlying) - Disposition to Issuer
Common Stock
2019-02-21$30.00/sh−3,745$112,350→ 0 total(indirect: By Trust) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−19,724→ 0 totalExercise: $16.81From: 2015-06-21Exp: 2025-05-20→ Common Stock (19,724 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−15,643→ 0 totalExercise: $22.78From: 2017-06-25Exp: 2024-05-24→ Common Stock (15,643 underlying) - Disposition to Issuer
Common Stock
2019-02-21$30.00/sh−105,439$3,163,170→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−15,854→ 0 totalExercise: $18.32From: 2016-06-26Exp: 2023-05-25→ Common Stock (15,854 underlying)
Footnotes (2)
- [F1]Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash.
- [F2]This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price.